Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Marco Fioramonti, Daniele Santini, Michele Iuliani, Giulia Ribelli, Paolo Manca, Nicola Papapietro, Filippo Spiezia, Bruno Vincenzi, Vincenzo Denaro, Antonio Russo, Giuseppe Tonini, Francesco Pantano
Published Feb 16, 2017 · Vol. 8, No. 12 · pp. 20113-20121
Cecelia R. Miller, Amy S. Ruppert, Sydney Fobare, Timothy L. Chen, Chaomei Liu, Amy Lehman, James S. Blachly, Xiaoli Zhang, David M. Lucas, Michael R. Grever, Martin S. Tallman, Ian W. Flinn, Laura Z. Rassenti, Thomas J. Kipps, Deepa Sampath, Kevin R. Coombes, Erin K. Hertlein
Published Feb 16, 2017 · Vol. 8, No. 16 · pp. 25942-25954
Leslimar RÃos-Colón, Christina K. Cajigas-Du Ross, Anamika Basu, Catherine Elix, Ivana Alicea-Polanco, Tino W. Sanchez, Vinodh Radhakrishnan, Chien-Shing Chen, Carlos A. Casiano
Published Feb 14, 2017 · Vol. 8, No. 15 · pp. 24915-24931